Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPALPP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CXorf49 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | MORC3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | CACHD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | SDE2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | INTU | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | SPATA6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NUP133 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | RP11-435I10.4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | XRN2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |